EligibleTrials

Clinical trials recruiting for Carcinoma

7
Recruiting trials
41
US states with sites
10
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 3Phase 2 3Not applicable 3

Drugs and treatments being studied

InterventionTrials
B7-H3 CAR T cells1
Chemotherapy Regimen 11
Chemotherapy Regimen 21
Cyclophosphamide1
Docetaxel (Taxotere)1
Fludarabine1
Irinotecan (Camptosar)1
Mesna1
Obinutuzumab 25 MG/1 ML Intravenous Solution [GAZYVA]1
PF-086344041
Pembrolizumab1
ST-0671

Where trials are recruiting (top US states)

StateRecruiting trials
Tennessee4
California3
Florida3
Massachusetts3
Alabama2
Arizona2
Colorado2
Connecticut2
Georgia2
Illinois2
Maryland2
Michigan2

Top cities

Albuquerque, New Mexico 2Bethesda, Maryland 2Boston, Massachusetts 2Buffalo, New York 2Columbus, Ohio 2Denver, Colorado 2Houston, Texas 2Memphis, Tennessee 2Miami, Florida 2Nashville, Tennessee 2

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Carcinoma often also study these conditions. Each links to its own recruiting-trial list.

Lung cancer 2180Non-small cell lung cancer 507Melanoma 487Pancreatic cancer 870Colorectal cancer 1359Breast cancer 2239Urothelial Carcinoma 29Urogenital Neoplasms 4Triple-negative breast cancer 138Testicular Cancer 11

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Carcinoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.